Market Outlook
The global Enzyme-Linked Immunosorbent Assay (ELISA) market size was valued at USD 184.2 million in 2022 and is forecast to a readjusted size of USD 233.5 million by 2029 with a CAGR of 3.4% during review period.
ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%. China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent. In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.
This report is a detailed and comprehensive analysis for global Enzyme-Linked Immunosorbent Assay (ELISA) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Enzyme-Linked Immunosorbent Assay (ELISA) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enzyme-Linked Immunosorbent Assay (ELISA)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enzyme-Linked Immunosorbent Assay (ELISA) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering
Segmentation By Type
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others
Segmentation By Application
Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Others
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the ELISA market in 2025?
The ELISA market is expected to benefit from its wide range of applications in diagnostics, vaccine development, and research. It offers high sensitivity, specificity, and cost-effectiveness, making it a go-to method for detecting infections, antibodies, and various biomarkers. Additionally, advancements in automation and multiplexing technology are enhancing its efficiency and appeal in clinical and research settings.
What are the weaknesses of the ELISA market in 2025?
One of the primary weaknesses is its susceptibility to human error in sample handling and result interpretation, which can lead to false positives or negatives. Moreover, while ELISA is cost-effective, the reagents and kits used for more specialized tests can still be expensive. The process also requires skilled technicians, which could limit its use in resource-constrained settings.
What opportunities are present for the ELISA market in 2025?
There are significant opportunities for growth as the demand for personalized medicine increases, with ELISA offering a valuable tool for biomarker discovery and disease monitoring. The market also stands to benefit from the increasing prevalence of chronic diseases and the rising demand for point-of-care testing. Moreover, the continued expansion of biotechnology and pharmaceutical sectors presents additional opportunities for collaboration and innovation in ELISA applications.
What threats might affect the ELISA market in 2025?
The main threats include the emergence of competing technologies, such as PCR-based diagnostics and other immunoassays, which may offer greater sensitivity or faster results. The complexity of regulatory approvals for new ELISA tests may also pose challenges, especially in countries with stringent regulatory requirements. Additionally, economic downturns could impact funding for research and development, potentially slowing market growth.
Market PESTEL Analysis
What are the political factors affecting the ELISA market in 2025?
Government regulations and policies related to healthcare, diagnostics, and research funding play a critical role in the ELISA market. Changes in healthcare policies or budget allocations can directly impact the availability of funding for research and the adoption of ELISA technologies. Furthermore, stricter regulations in different regions can affect the approval process for new ELISA-based tests, influencing market growth.
How do economic factors influence the ELISA market in 2025?
Economic conditions, such as healthcare expenditure and disposable income, can impact the demand for diagnostic tests, including ELISA. During economic downturns, healthcare budgets may be restricted, leading to reduced investment in advanced diagnostic technologies. However, in emerging markets, growing healthcare spending presents an opportunity for ELISA adoption as healthcare infrastructure improves.
What social factors are influencing the ELISA market in 2025?
There is an increasing societal awareness of health and wellness, driving demand for better diagnostic tools like ELISA for early disease detection. The rise of personalized medicine and growing chronic disease prevalence contribute to this trend. Additionally, patient preferences for non-invasive, accurate, and rapid testing options further fuel the demand for ELISA technologies.
How do technological factors impact the ELISA market in 2025?
Advances in automation, multiplexing, and microfluidics are significantly improving the efficiency and accuracy of ELISA tests. Technological innovations that make ELISA more user-friendly, quicker, and cost-effective can enhance its adoption across research and clinical labs. However, the rise of alternative technologies like PCR and next-generation sequencing could pose a challenge to the dominance of ELISA.
What environmental factors are relevant to the ELISA market in 2025?
Environmental concerns, particularly those related to the disposal of medical waste and the use of environmentally harmful reagents, may lead to stricter regulations around ELISA kits. There is also a growing emphasis on sustainability, which could drive demand for eco-friendly and biodegradable materials in diagnostic test kits.
What legal factors could affect the ELISA market in 2025?
The ELISA market is subject to stringent regulatory and intellectual property laws, which affect the approval and commercialization of new tests. Intellectual property rights related to innovative ELISA technologies could lead to patent disputes. Moreover, changes in healthcare laws, such as data privacy regulations, could impact the way patient samples are handled and analyzed, affecting the market’s operational landscape.
Market SIPOC Analysis
What is the Supplier in the SIPOC analysis of the ELISA market 2025?
Suppliers include biotechnology firms, reagent manufacturers, and research institutions that provide essential components like antibodies, enzymes, substrates, and detection systems. Additionally, raw material providers supply plastics for microplates, buffers, and stabilizers crucial for assay development.
Who are the Inputs providers in the ELISA market?
Inputs come from manufacturers of assay reagents, microplates, detection chemicals, and calibration standards. Advanced technology providers contribute automated ELISA analyzers, software for data analysis, and innovations in assay sensitivity and specificity. Regulatory agencies also influence input selection through compliance requirements.
What is the Process in the ELISA market?
The process involves R&D for assay development, optimization of sensitivity and specificity, large-scale production, and stringent quality control. It also includes regulatory approval processes, packaging, distribution, and training for end-users. Technological advancements, such as multiplex ELISA and automation, further refine workflows, increasing efficiency and accuracy.
Who are the Outputs receivers in this market?
Outputs include commercially available ELISA test kits for disease diagnostics, drug development, food safety testing, and veterinary applications. Custom assay solutions, laboratory consumables, and software for result interpretation are also key deliverables. The increasing demand for rapid and high-throughput ELISA solutions has led to innovations in portable and automated ELISA systems.
Who are the Customers in the ELISA market?
Customers include hospitals, clinical laboratories, pharmaceutical and biotech companies, research institutions, and government agencies. They use ELISA for disease diagnosis (e.g., infectious diseases, cancer biomarkers), therapeutic drug monitoring, vaccine development, and environmental and food safety testing. The growing prevalence of chronic and infectious diseases continues to drive market expansion, with an increasing shift toward point-of-care and high-throughput ELISA applications.
Market Porter's Five Forces
What is the Competitive Rivalry in the ELISA market 2025?
The ELISA market is highly competitive, with key players including biotechnology firms, diagnostic companies, and research institutions. Intense competition drives continuous innovation, leading to improved assay sensitivity, automation, and multiplexing capabilities. Price wars and the need for regulatory compliance further increase market pressure.
What is the Threat of New Entrants in the ELISA market?
The threat of new entrants is moderate to high due to the growing demand for diagnostics and research tools. However, significant barriers exist, such as the high cost of R&D, stringent regulatory approvals, and the need for established distribution networks. Established players maintain a competitive edge through patents and brand reputation.
What is the Bargaining Power of Suppliers in the ELISA market?
Suppliers of critical raw materials, such as antibodies, enzymes, and substrates, hold moderate bargaining power. Their influence depends on the availability of alternative sources and the specificity of reagents. Suppliers with proprietary technologies or unique reagents have stronger leverage over manufacturers.
What is the Bargaining Power of Buyers in the ELISA market?
Buyers, including hospitals, laboratories, and research institutions, have moderate to high bargaining power. With multiple suppliers available, they can negotiate better pricing, demand high-quality standards, and seek customized solutions. Large healthcare organizations and government agencies have stronger influence due to bulk purchasing power.
What is the Threat of Substitutes in the ELISA market?
The threat of substitutes is growing, with emerging technologies like polymerase chain reaction (PCR), next-generation sequencing (NGS), and biosensors offering alternative detection methods. However, ELISA remains a preferred choice due to its cost-effectiveness, ease of use, and well-established validation in diagnostics and research.
Market Upstream Analysis
What are the key upstream components in the ELISA market 2025?
The key upstream components include antibodies, enzymes, substrates, microplates, buffers, and stabilizers. These materials are essential for the development and manufacturing of ELISA kits, influencing assay performance and reliability.
Who are the primary suppliers in the ELISA market upstream?
Suppliers consist of biotechnology companies, chemical manufacturers, and specialized reagent providers. Companies producing high-affinity antibodies, recombinant enzymes, and high-purity substrates play a critical role in ensuring assay sensitivity and specificity.
What are the challenges in the upstream supply chain of ELISA?
Challenges include fluctuations in raw material availability, supply chain disruptions, and regulatory constraints. Variability in antibody production, dependency on cold-chain logistics, and the need for GMP-compliant manufacturing can impact production timelines and costs.
How do regulatory requirements affect the upstream ELISA market?
Stringent regulatory guidelines govern the production and sourcing of ELISA components, ensuring quality, safety, and consistency. Compliance with FDA, EMA, and ISO standards adds complexity to sourcing raw materials and requires rigorous quality control measures.
What are the emerging trends in the upstream ELISA market?
Advancements in recombinant antibody technology, sustainable manufacturing practices, and automation in reagent production are key trends. Increasing demand for high-throughput and multiplex ELISA is driving innovation in raw material formulations and supply chain optimization.
Market Midstream Analysis
What are the key midstream activities in the ELISA market 2025?
Midstream activities focus on the manufacturing, quality control, and packaging of ELISA kits. This includes optimizing assay formulations, ensuring batch-to-batch consistency, validating performance, and adhering to regulatory standards before distribution.
Who are the main players involved in the midstream ELISA market?
Midstream players include diagnostic companies, biotech firms, and contract manufacturing organizations (CMOs) responsible for large-scale production. These entities handle process optimization, automation, and compliance with international quality standards.
What are the major challenges in the midstream ELISA market?
Challenges include maintaining product consistency, reducing production costs, and meeting stringent regulatory approvals. The need for automation and high-throughput manufacturing also presents logistical and technological hurdles.
How does technology impact the midstream ELISA process?
Automation, AI-driven quality control, and advanced assay development techniques enhance efficiency and reliability. Innovations such as multiplex ELISA and improved plate-coating methods streamline production while increasing assay sensitivity.
What trends are shaping the midstream ELISA market?
Key trends include the shift toward automated manufacturing, increased outsourcing to CMOs, and a growing emphasis on eco-friendly production methods. Companies are also investing in scalable processes to meet rising global demand for diagnostic and research applications.
Market Downstream Analysis
Who are the key downstream users in the ELISA market 2025?
Downstream users include hospitals, diagnostic laboratories, research institutions, pharmaceutical companies, and food safety agencies. They utilize ELISA kits for disease diagnostics, drug development, biomarker detection, and quality control applications.
What are the major challenges faced by downstream users?
Challenges include ensuring assay accuracy, managing high testing volumes, and interpreting complex data. Cost constraints, regulatory compliance, and the need for skilled personnel also impact the efficient use of ELISA in clinical and research settings.
How is technology influencing the downstream ELISA market?
Automation, AI-driven data analysis, and cloud-based reporting are streamlining workflows, reducing human error, and enhancing result interpretation. Portable and high-throughput ELISA systems are improving accessibility and efficiency for end-users.
What trends are shaping the downstream ELISA market?
Key trends include increasing adoption of point-of-care ELISA, growing demand for rapid diagnostics, and integration with digital health platforms. Personalized medicine and precision diagnostics are also driving innovation in assay development and application.
How does regulatory compliance affect downstream ELISA adoption?
Regulatory guidelines ensure test accuracy, reliability, and patient safety. Compliance with FDA, CE, and ISO standards is crucial for clinical adoption, while research applications require adherence to Good Laboratory Practices (GLP) and quality assurance protocols.
Chapter 1, to describe Enzyme-Linked Immunosorbent Assay (ELISA) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Enzyme-Linked Immunosorbent Assay (ELISA), with revenue, gross margin and global market share of Enzyme-Linked Immunosorbent Assay (ELISA) from 2018 to 2023.
Chapter 3, the Enzyme-Linked Immunosorbent Assay (ELISA) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Enzyme-Linked Immunosorbent Assay (ELISA) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Enzyme-Linked Immunosorbent Assay (ELISA).
Chapter 13, to describe Enzyme-Linked Immunosorbent Assay (ELISA) research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Enzyme-Linked Immunosorbent Assay (ELISA)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Enzyme-Linked Immunosorbent Assay (ELISA) by Type
1.3.1 Overview: Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Type in 2022
1.3.3 Sandwich ELISA
1.3.4 Indirect ELISA
1.3.5 Competitive ELISA
1.3.6 Others
1.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market by Application
1.4.1 Overview: Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immunology
1.4.3 Inflammation
1.4.4 Infectious Diseases
1.4.5 Cancer
1.4.6 Protein Quantitation
1.4.7 Others
1.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size & Forecast
1.6 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast by Region
1.6.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region, (2018-2029)
1.6.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2018-2029)
1.6.4 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2018-2029)
1.6.6 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 R&D Systems
2.1.1 R&D Systems Details
2.1.2 R&D Systems Major Business
2.1.3 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.1.4 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 R&D Systems Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.2.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Ortho Clinical Diagnostics
2.3.1 Ortho Clinical Diagnostics Details
2.3.2 Ortho Clinical Diagnostics Major Business
2.3.3 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.3.4 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
2.4 BD Biosciences
2.4.1 BD Biosciences Details
2.4.2 BD Biosciences Major Business
2.4.3 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.4.4 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BD Biosciences Recent Developments and Future Plans
2.5 ZEUS Scientific
2.5.1 ZEUS Scientific Details
2.5.2 ZEUS Scientific Major Business
2.5.3 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.5.4 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 ZEUS Scientific Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.6.4 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.7 ALPCO
2.7.1 ALPCO Details
2.7.2 ALPCO Major Business
2.7.3 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.7.4 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 ALPCO Recent Developments and Future Plans
2.8 Enzo Life Sciences
2.8.1 Enzo Life Sciences Details
2.8.2 Enzo Life Sciences Major Business
2.8.3 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.8.4 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Enzo Life Sciences Recent Developments and Future Plans
2.9 BioMérieux
2.9.1 BioMérieux Details
2.9.2 BioMérieux Major Business
2.9.3 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.9.4 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BioMérieux Recent Developments and Future Plans
2.10 EMD Millipore
2.10.1 EMD Millipore Details
2.10.2 EMD Millipore Major Business
2.10.3 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.10.4 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 EMD Millipore Recent Developments and Future Plans
2.11 BioLegend
2.11.1 BioLegend Details
2.11.2 BioLegend Major Business
2.11.3 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.11.4 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BioLegend Recent Developments and Future Plans
2.12 LOEWE Biochemica
2.12.1 LOEWE Biochemica Details
2.12.2 LOEWE Biochemica Major Business
2.12.3 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.12.4 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 LOEWE Biochemica Recent Developments and Future Plans
2.13 Mercodia
2.13.1 Mercodia Details
2.13.2 Mercodia Major Business
2.13.3 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.13.4 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Mercodia Recent Developments and Future Plans
2.14 Cusabio
2.14.1 Cusabio Details
2.14.2 Cusabio Major Business
2.14.3 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.14.4 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Cusabio Recent Developments and Future Plans
2.15 Shanghai Kehua Bio-engineering
2.15.1 Shanghai Kehua Bio-engineering Details
2.15.2 Shanghai Kehua Bio-engineering Major Business
2.15.3 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.15.4 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Shanghai Kehua Bio-engineering Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Enzyme-Linked Immunosorbent Assay (ELISA) by Company Revenue
3.2.2 Top 3 Enzyme-Linked Immunosorbent Assay (ELISA) Players Market Share in 2022
3.2.3 Top 6 Enzyme-Linked Immunosorbent Assay (ELISA) Players Market Share in 2022
3.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market: Overall Company Footprint Analysis
3.3.1 Enzyme-Linked Immunosorbent Assay (ELISA) Market: Region Footprint
3.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market: Company Product Type Footprint
3.3.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Application (2018-2023)
5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Forecast by Application (2024-2029)
6 North America
6.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2018-2029)
6.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2018-2029)
6.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
6.3.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2018-2029)
6.3.2 United States Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
6.3.3 Canada Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
6.3.4 Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2018-2029)
7.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2018-2029)
7.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
7.3.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2018-2029)
7.3.2 Germany Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
7.3.3 France Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
7.3.5 Russia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
7.3.6 Italy Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region
8.3.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Region (2018-2029)
8.3.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
8.3.3 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
8.3.4 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
8.3.5 India Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
8.3.7 Australia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
9 South America
9.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2018-2029)
9.2 South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2018-2029)
9.3 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
9.3.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2018-2029)
9.3.2 Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
9.3.3 Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
10.3.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2018-2029)
10.3.2 Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
10.3.4 UAE Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers
11.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
11.3 Enzyme-Linked Immunosorbent Assay (ELISA) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Chain
12.2 Enzyme-Linked Immunosorbent Assay (ELISA) Upstream Analysis
12.3 Enzyme-Linked Immunosorbent Assay (ELISA) Midstream Analysis
12.4 Enzyme-Linked Immunosorbent Assay (ELISA) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. R&D Systems Company Information, Head Office, and Major Competitors
Table 6. R&D Systems Major Business
Table 7. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 8. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. R&D Systems Recent Developments and Future Plans
Table 10. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 13. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Thermo Fisher Scientific Recent Developments and Future Plans
Table 15. Ortho Clinical Diagnostics Company Information, Head Office, and Major Competitors
Table 16. Ortho Clinical Diagnostics Major Business
Table 17. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 18. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Ortho Clinical Diagnostics Recent Developments and Future Plans
Table 20. BD Biosciences Company Information, Head Office, and Major Competitors
Table 21. BD Biosciences Major Business
Table 22. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 23. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. BD Biosciences Recent Developments and Future Plans
Table 25. ZEUS Scientific Company Information, Head Office, and Major Competitors
Table 26. ZEUS Scientific Major Business
Table 27. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 28. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. ZEUS Scientific Recent Developments and Future Plans
Table 30. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 31. Bio-Rad Laboratories Major Business
Table 32. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 33. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bio-Rad Laboratories Recent Developments and Future Plans
Table 35. ALPCO Company Information, Head Office, and Major Competitors
Table 36. ALPCO Major Business
Table 37. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 38. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. ALPCO Recent Developments and Future Plans
Table 40. Enzo Life Sciences Company Information, Head Office, and Major Competitors
Table 41. Enzo Life Sciences Major Business
Table 42. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 43. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Enzo Life Sciences Recent Developments and Future Plans
Table 45. BioMérieux Company Information, Head Office, and Major Competitors
Table 46. BioMérieux Major Business
Table 47. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 48. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. BioMérieux Recent Developments and Future Plans
Table 50. EMD Millipore Company Information, Head Office, and Major Competitors
Table 51. EMD Millipore Major Business
Table 52. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 53. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. EMD Millipore Recent Developments and Future Plans
Table 55. BioLegend Company Information, Head Office, and Major Competitors
Table 56. BioLegend Major Business
Table 57. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 58. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BioLegend Recent Developments and Future Plans
Table 60. LOEWE Biochemica Company Information, Head Office, and Major Competitors
Table 61. LOEWE Biochemica Major Business
Table 62. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 63. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. LOEWE Biochemica Recent Developments and Future Plans
Table 65. Mercodia Company Information, Head Office, and Major Competitors
Table 66. Mercodia Major Business
Table 67. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 68. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Mercodia Recent Developments and Future Plans
Table 70. Cusabio Company Information, Head Office, and Major Competitors
Table 71. Cusabio Major Business
Table 72. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 73. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Cusabio Recent Developments and Future Plans
Table 75. Shanghai Kehua Bio-engineering Company Information, Head Office, and Major Competitors
Table 76. Shanghai Kehua Bio-engineering Major Business
Table 77. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 78. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Shanghai Kehua Bio-engineering Recent Developments and Future Plans
Table 80. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) by Players (2018-2023)
Table 81. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Players (2018-2023)
Table 82. Breakdown of Enzyme-Linked Immunosorbent Assay (ELISA) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Enzyme-Linked Immunosorbent Assay (ELISA), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Enzyme-Linked Immunosorbent Assay (ELISA) Players
Table 85. Enzyme-Linked Immunosorbent Assay (ELISA) Market: Company Product Type Footprint
Table 86. Enzyme-Linked Immunosorbent Assay (ELISA) Market: Company Product Application Footprint
Table 87. Enzyme-Linked Immunosorbent Assay (ELISA) New Market Entrants and Barriers to Market Entry
Table 88. Enzyme-Linked Immunosorbent Assay (ELISA) Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Share by Type (2018-2023)
Table 91. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Forecast by Type (2024-2029)
Table 92. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2018-2023)
Table 93. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Forecast by Application (2024-2029)
Table 94. North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Enzyme-Linked Immunosorbent Assay (ELISA) Raw Material
Table 125. Key Suppliers of Enzyme-Linked Immunosorbent Assay (ELISA) Raw Materials
List of Figures
Figure 1. Enzyme-Linked Immunosorbent Assay (ELISA) Picture
Figure 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Type in 2022
Figure 4. Sandwich ELISA
Figure 5. Indirect ELISA
Figure 6. Competitive ELISA
Figure 7. Others
Figure 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Application in 2022
Figure 10. Immunology Picture
Figure 11. Inflammation Picture
Figure 12. Infectious Diseases Picture
Figure 13. Cancer Picture
Figure 14. Protein Quantitation Picture
Figure 15. Others Picture
Figure 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Region in 2022
Figure 21. North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Players in 2022
Figure 27. Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 28. Global Top 3 Players Enzyme-Linked Immunosorbent Assay (ELISA) Market Share in 2022
Figure 29. Global Top 6 Players Enzyme-Linked Immunosorbent Assay (ELISA) Market Share in 2022
Figure 30. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Share by Type (2018-2023)
Figure 31. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share Forecast by Type (2024-2029)
Figure 32. Global Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Share by Application (2018-2023)
Figure 33. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share Forecast by Application (2024-2029)
Figure 34. North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Type (2018-2029)
Figure 35. North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Application (2018-2029)
Figure 36. North America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 38. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 39. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 40. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Type (2018-2029)
Figure 41. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Application (2018-2029)
Figure 42. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 44. France Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 45. United Kingdom Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 46. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 47. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Region (2018-2029)
Figure 51. China Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 52. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 53. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 54. India Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 55. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 56. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 57. South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Type (2018-2029)
Figure 58. South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Application (2018-2029)
Figure 59. South America Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Country (2018-2029)
Figure 60. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 61. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 62. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Type (2018-2029)
Figure 63. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Application (2018-2029)
Figure 64. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value Market Share by Country (2018-2029)
Figure 65. Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 66. Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 67. UAE Enzyme-Linked Immunosorbent Assay (ELISA) Consumption Value (2018-2029) & (USD Million)
Figure 68. Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers
Figure 69. Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
Figure 70. Enzyme-Linked Immunosorbent Assay (ELISA) Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Enzyme-Linked Immunosorbent Assay (ELISA) in 2022
Figure 73. Manufacturing Process Analysis of Enzyme-Linked Immunosorbent Assay (ELISA)
Figure 74. Enzyme-Linked Immunosorbent Assay (ELISA) Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
